KRAS-Driven Lung Adenocarcinoma and B Cell Infiltration: Novel Insights for Immunotherapy

Non-small-cell lung cancer, histologically classified into adenocarcinoma (AD) and squamous cell carcinoma, is one of the most deadly malignancies worldwide. Lung AD (LUAD) could benefit of a plethora of target therapies and, in the last few years, also of immunotherapies. Here we focused on a real-...

Descripción completa

Detalles Bibliográficos
Autores principales: Rosamaria, Pinto, Daniela, Petriella, Rosanna, Lacalamita, Michele, Montrone, Annamaria, Catino, Pamela, Pizzutilo, Antonietta, Botticella Maria, Alfredo, Zito Francesco, Gabriella, Del Bene, Antonia, Zonno, Stefania, Tommasi, Simona, De Summa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721568/
https://www.ncbi.nlm.nih.gov/pubmed/31405063
http://dx.doi.org/10.3390/cancers11081145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721568/
https://www.ncbi.nlm.nih.gov/pubmed/31405063
http://dx.doi.org/10.3390/cancers11081145

Ejemplares similares